Factors influencing haemostasis and blood transfusion in cardiac surgery
暂无分享,去创建一个
D. Roberts | Bo Liu | A. Belboul | S. Larsson
[1] S. Khuri,et al. Effects of Cardiopulmonary Bypass on Hemostasis , 1997 .
[2] K. Taylor. Perioperative approaches to coagulation defects. , 1993, The Annals of thoracic surgery.
[3] L. Edmunds. Blood‐Surface Interactions During Cardiopulmonary Bypass , 1993, Journal of cardiac surgery.
[4] G. Beck,et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. , 1992, JAMA.
[5] M. Halfman-Franey,et al. Recognition and management of bleeding following cardiac surgery. , 1991, Critical care nursing clinics of North America.
[6] A. Belboul,et al. High-dose aprotinin (trasylol) in reducing bleeding and protecting lung function in potential bleeders undergoing cardiopulmonary bypass. , 1991, Chinese medical journal.
[7] A. van Breda,et al. Thrombolysis in Arterial Bypass Grafts , 1991, Seminars in thrombosis and hemostasis.
[8] S. Khuri,et al. Hematologic Changes During and Following Cardiopulmonary Bypass and Their Relationship to Non-Surgical Blood Loss. 1. Platelet Function and the Bleeding Time. , 1990 .
[9] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[10] A. Bernstein,et al. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.
[11] K. M. Taylor,et al. EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.
[12] S. Lemeshow,et al. Blood conservation for myocardial revascularization. Is it cost effective? , 1987, The Journal of thoracic and cardiovascular surgery.
[13] M. Dechavanne,et al. Significant Reduction in the Binding of a Monoclonal Antibody (LYP 18) Directed Against the IIb/IIIa Glycoprotein Complex to Platelets of Patients Having Undergone Extracorporeal Circulation , 1987, Thrombosis and Haemostasis.
[14] S Westaby,et al. Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.
[15] E. Hessel,et al. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.
[16] E. Michelson,et al. Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. , 1980, American journal of surgery.
[17] P. Biglioli,et al. The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991). , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[18] W. van Oeveren,et al. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. , 1994, European Journal of Cardio-Thoracic Surgery.
[19] D. Roberts,et al. Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.
[20] A. Michelson. Pathomechanism of Defective Hemostasis During and After Extracorporeal Circulation: The Role of Platelets , 1991 .
[21] D. Roberts,et al. Association between bleeding and reduced red cell deformability following cardiopulmonary bypass. , 1988, Scandinavian journal of thoracic and cardiovascular surgery.